Cite
HER2 Isoforms Uniquely Program Intratumor Heterogeneity and Predetermine Breast Cancer Trajectories During the Occult Tumorigenic Phase
MLA
Joshua D. Ginzel, et al. “HER2 Isoforms Uniquely Program Intratumor Heterogeneity and Predetermine Breast Cancer Trajectories During the Occult Tumorigenic Phase.” Molecular Cancer Research : MCR, vol. 19, no. 10, Mar. 2021. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....3c799658e9caec1d1e76a3e04ecd77ab&authtype=sso&custid=ns315887.
APA
Joshua D. Ginzel, Joshua C. Snyder, Marc G. Caron, Peter G. Boone, Veronica Lubkov, H. Kim Lyerly, Alexander D. Borowsky, Hidetoshi Mori, Erika J. Crosby, Lauren K. Rochelle, Zachary C. Hartman, Larry S. Barak, Neil E. Hubbard, Chaitanya R. Acharya, Wendy Roberts, Jeffrey I. Everitt, Robert D. Cardiff, & Jane Q. Chen. (2021). HER2 Isoforms Uniquely Program Intratumor Heterogeneity and Predetermine Breast Cancer Trajectories During the Occult Tumorigenic Phase. Molecular Cancer Research : MCR, 19(10).
Chicago
Joshua D. Ginzel, Joshua C. Snyder, Marc G. Caron, Peter G. Boone, Veronica Lubkov, H. Kim Lyerly, Alexander D. Borowsky, et al. 2021. “HER2 Isoforms Uniquely Program Intratumor Heterogeneity and Predetermine Breast Cancer Trajectories During the Occult Tumorigenic Phase.” Molecular Cancer Research : MCR 19 (10). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....3c799658e9caec1d1e76a3e04ecd77ab&authtype=sso&custid=ns315887.